Xenon Pharmaceuticals' (XENE) "Outperform" Rating Reiterated at Royal Bank of Canada theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Prelude Capital Management LLC Has $788,000 Holdings in Xenon Pharmaceuticals Inc. (NASDAQ:XENE) themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Xenon Pharmaceuticals Inc. (NASDAQ:XENE – Get Free Report) has been assigned a consensus recommendation of “Buy” from the eleven brokerages that are presently covering the stock, MarketBeat Ratings reports. Ten research analysts have rated the stock with a buy rating and one has issued a strong buy rating on the company. The average 1-year price […]
Candriam S.C.A. lessened its stake in Xenon Pharmaceuticals Inc. (NASDAQ:XENE – Free Report) by 2.3% in the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 719,206 shares of the biopharmaceutical company’s stock after selling 16,678 shares during the quarter. Candriam S.C.A.’s holdings […]
Candriam S.C.A. trimmed its holdings in Xenon Pharmaceuticals Inc. (NASDAQ:XENE – Free Report) by 2.3% in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 719,206 shares of the biopharmaceutical company’s stock after selling 16,678 shares during the quarter. Candriam S.C.A. owned 1.14% of Xenon […]